Healthcare Enforcement Roundup - Volume 1, 2021

Stay current on the healthcare enforcement issues impacting your business’ compliance strategies. In this installment of the Healthcare Enforcement Roundup, we address:

• Key areas of enforcement scrutiny in 2021, including growing numbers of relator complaints under the False Claims Act, COVID-19-related enforcement, and ongoing attention to private equity;

• Timely updates on Section 1135 waivers, telemedicine-related issues, and further interpretation regarding the enforceability of sub-regulatory guidance;

• The Office of Inspector General’s Special Fraud Alert, which provides important guidelines for pharmaceutical and medical device speaker programs; and

• Pertinent developments in cases and other enforcement matters covered in prior issues...

Please see full Publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

McDermott Will & Emery
Contact
more
less

McDermott Will & Emery on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.